Document is current
Any future updates will be listed below
-
Authors
Kuryk, Lukasz
Mathlouthi, Sara
Casagrande, Lisa
Pesce, Cristiano
Tognetti, Francesco
Malfanti, Alessio
Masny, Aleksander
Caliceti, Paolo
Garofalo, Mariangela https://orcid.org/0000-0002-5001-7826
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova (GARO_BIRD23_01)
Ministero dell’Istruzione, dell’Università e della Ricerca (CN00000041)
Narodowe Centrum Nauki (2022/47/D/NZ7/03212)
Narodowe Centrum Badań i Rozwoju (0258/L-14/2023)
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 10 October 2025
First Online: 3 November 2025
Declarations
:
: Not applicable.
: We, the authors, give our full consent for the publication of our manuscript titled: “Dynamic 3D Microfluidic Platform for Exploring Combined Targeted Therapy, Chemotherapy, and Virotherapy Delivery in Ovarian Cancer” in Drug Delivery and Translational Research, confirming that we have contributed to the work, reviewed the final version, and agreed to its submission. We affirm that the manuscript is original and complies with ethical and copyright requirements .
: Author L.K. is an employee and/or shareholder in Valo Therapeutics. The other authors declare that the work was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
